EMERGENCY MEDICINEPub Date : 2024-01-11DOI: 10.22141/2224-0586.19.8.2023.1639
M.S. Cherska, H.M. Kukharchuk
{"title":"Cardiovascular diseases and energy deficiency: pathogenetic ways of correction","authors":"M.S. Cherska, H.M. Kukharchuk","doi":"10.22141/2224-0586.19.8.2023.1639","DOIUrl":"https://doi.org/10.22141/2224-0586.19.8.2023.1639","url":null,"abstract":"Cardiovascular disease remains one of the most common and influential causes of death worldwide, as the heart plays a key role in the human body. Energetic cardioprotective therapy of the myocardium is an important protective factor, regulating the synthesis and use of energy by myocardial cells, while having a little effect on heart rate, blood pressure, and blood supply. Phosphocreatine plays an important role in the intracellular energy buffering and transport system, ensuring energy transfer from the site of production to the site of use to meet the high and variable demands of the heart. Research shows that phosphocreatine can have a positive effect on patients with coronary heart disease, heart failure, and those who have undergone cardiac surgery. The accumulated information confirms the prospects of using phosphocreatine in clinical practice to improve treatment outcomes in patients with heart diseases.","PeriodicalId":510128,"journal":{"name":"EMERGENCY MEDICINE","volume":"36 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139534128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EMERGENCY MEDICINEPub Date : 2024-01-11DOI: 10.22141/2224-0586.19.8.2023.1644
V. Tseluyko, O. Butko
{"title":"ECG changes and their prognostic value for the development of sudden cardiac death in HCM patients","authors":"V. Tseluyko, O. Butko","doi":"10.22141/2224-0586.19.8.2023.1644","DOIUrl":"https://doi.org/10.22141/2224-0586.19.8.2023.1644","url":null,"abstract":"Background. Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease characterized by an increase in the left ventricular (LV) wall thickness, which is not explained only by abnormal loading conditions. The development of sudden cardiac death (SCD) is one of the most dangerous complications of HCM. The aim of our study was to evaluate the prognostic value of electrocardiography (ECG) changes for the development of SCD in the Ukrainian population of patients with HCM. Materials and methods. We evaluated 350 patients with HCM who were examined in the City Clinical Hospital 8 (Kharkiv, Ukraine) from 2006 to 2021. The diagnosis of HCM was made in accordance with the current guidelines of the European Society of Cardiology. Clinical and instrumental data of patients with HCM were analyzed retrospectively, including general clinical data, 12-lead ECG, echocardiography, Holter monitoring, calculation of the 5-year risk of SCD according to the HCM Risk-SCD tool. The endpoint of the study was SCD and its surrogates, including adequate performance of the implantable cardioverter-defibrillator and the state after a successful resuscitation. Results. Follow-up was 5.0 (1.5–9.5) years. During this time, 16 patients (4.6 %) reached the endpoint, which was 0.9 %/year. According to the HCM Risk-SCD, 5 (31.3 %) patients in this group were at a high (≥ 6 %) and 3 (18.8 %) were at an intermediate risk of SCD (≥ 4 and < 6 %). A multivariable Cox regression analysis has shown that independent predictors of SCD are syncope (hazard ratio (HR) 3.81, 95% confidence interval (CI) 1.11–13.12, p = 0.034), systolic blood pressure (HR 0.97, 95% CI 0.94–0.99, p = 0.026), ECG with “infarction-like” ST elevation (HR 6.81, 95% CI 2.09–22.16, p = 0.001) and PQ interval value (HR 1.03, 95% CI 1.01–1.05, p = 0.002), Harrell’s C-index (HR 0.84, 95% CI 0.73–0.95, p < 0.0001). Conclusions. The proposed HCM Risk-SCD tool was not effective enough in predicting SCD in our study. In order to improve the risk stratification, ECG changes (“infarction-like” ST elevation and PQ interval prolongation) and systolic blood pressure lowering can be used, which were found to be independent predictors of SCD risk.","PeriodicalId":510128,"journal":{"name":"EMERGENCY MEDICINE","volume":"11 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EMERGENCY MEDICINEPub Date : 2024-01-11DOI: 10.22141/2224-0586.19.8.2023.1643
K. Denysiuk
{"title":"Optimisation of conservative treatment of patients with severe heart failure by using hemosorption","authors":"K. Denysiuk","doi":"10.22141/2224-0586.19.8.2023.1643","DOIUrl":"https://doi.org/10.22141/2224-0586.19.8.2023.1643","url":null,"abstract":"Background. Heart failure (HF) is a complex cardiac pathology that is the main cause of hospitalisation among adults and is characterised by a high mortality. Dilated cardiomyopathy (DCM) is the most common cause of HF, and it can be fatal within a few years after the first symptoms appear. Many patients with HF remain refractory to medical therapy, despite its constant development and improvement. The study aims to compare the effectiveness of conservative treatment of patients with severe HF that occurred on the background of DCM using drug therapy and its combination with a course of hemosorption (HS). Materials and methods. We analysed treatment outcomes in 30 patients with severe HF against DCM (New York Heart Association class III–V, left ventricular ejection fraction (LV EF) < 30 %). Patients in group 1 (n = 13; N-terminal fragment of brain natriuretic peptide precursor (NT-pro BNP) 4,546.23 ± ± 3,265.01 pg/ml; LV EF 16.77 ± 2.92 %; LV end-diastolic volume (EDV) 261.31 ± 60.60 ml, LV end-systolic volume (ESV) 214.85 ± 49.44 ml) received drug therapy according to local protocols. In group 2 (n = 17; NT-pro BNP 3,974.49 ± 3,550.17 pg/ml; LV EF 18.18 ± 4.36 %; LV EDV 261.12 ± 79.96 ml, LV ESV 212.06 ± 71.67 ml), medical treatment was supplemented with a course of 3 HS procedures using granular deligandizing hemosorbent. Results. Patients in both study groups noted an improvement in well-being and a decrease in the severity of symptoms. The level of NT-pro BNP decreased to 2,609.92 ± 1,465.14 pg/ml (p < 0.01) in group 1 and to 975.35 ± 511.55 pg/ml (p < 0.05) in group 2. LV EF increased to 22.77 ± 4.69 % and 26.76 ± 5.02 %, respectively, in the groups (p < 0.01). In patients of group 1, LV EDV and LV ESV changed to 262.22 ± 40.92 ml and 211.33 ± 35.22 ml, respectively. In group 2, there was a significant decrease in LV EDV to 228.94 ± 73.16 ml and LV ESV to 170.88 ± 60.28 ml (p < 0.01). Conclusions. The use of HS in combination with drug therapy for severe HF on the background of DCM improves the clinical status of patients and LV systolic function.","PeriodicalId":510128,"journal":{"name":"EMERGENCY MEDICINE","volume":"5 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EMERGENCY MEDICINEPub Date : 2024-01-11DOI: 10.22141/2224-0586.19.8.2023.1645
Zh.O. Ushnevych, N. Matolinets
{"title":"Analysis of biomarkers of stress in the perioperative period during surgical treatment for abdominal wall hernias","authors":"Zh.O. Ushnevych, N. Matolinets","doi":"10.22141/2224-0586.19.8.2023.1645","DOIUrl":"https://doi.org/10.22141/2224-0586.19.8.2023.1645","url":null,"abstract":"Background. Pain impairs the patient’s quality of life after surgery and, causing a significant stress, affects life expectancy. Many biomarkers (albumin, hemoglobin, glucose level, C-reactive protein) are used to objectively assess stress, but their levels depending on the type of analgesia and their role in predicting the course of the postoperative period have not been fully studied. Aim: to conduct a comparative analysis of biomarkers of stress in patients undergoing surgery for abdominal wall hernias depending on the type of perioperative analgesia. Materials and methods. Sixty-three patients who underwent surgical treatment for abdominal wall hernias took part in the study. They were divided into 3 groups according to the method of anesthesia (general, neuraxial and regional blockades). At different stages of the perioperative period, the dynamics of stress biomarkers such as cortisol and blood glucose was studied. Results. Before the operation, the blood glucose level did not differ significantly in three groups. During the traumatic period of surgical treatment, stress-induced hyperglycemia developed, its level did not depend on the type of anesthesia performed, and 24 hours after the operation, the level of glycemia significantly decreased to normal one. A significant increase in cortisol was registered in group 1. At the same time, on the contrary, the blood cortisol level decreased in patients of groups 2 and 3. After 24 hours, the blood cortisol level decreased to normal values, and in all groups, it was lower than that before surgery. Conclusions. Regardless of the type of anesthetic management, an increase in blood glucose levels was recorded in patients of all three groups during surgical treatment for abdominal wall hernias. Patients undergoing regional abdominal wall blocks had lower levels of stress biomarkers after surgery and 24 hours postoperatively compared to general anesthesia.","PeriodicalId":510128,"journal":{"name":"EMERGENCY MEDICINE","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}